- Home
- BTM vs ASBP Comparison
BTM vs ASBP Comparison
Compare BTM & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTM
- ASBP
- Stock Information
- Founded
- BTM 2016
- ASBP 2021
- Country
- BTM United States
- ASBP United States
- Employees
- BTM N/A
- ASBP N/A
- Industry
- BTM Finance: Consumer Services
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- BTM Finance
- ASBP Health Care
- Exchange
- BTM Nasdaq
- ASBP Nasdaq
- Market Cap
- BTM 23.1M
- ASBP 26.6M
- IPO Year
- BTM N/A
- ASBP N/A
- Fundamental
- Price
- BTM $1.41
- ASBP $0.52
- Analyst Decision
- BTM Strong Buy
- ASBP
- Analyst Count
- BTM 2
- ASBP 0
- Target Price
- BTM $4.35
- ASBP N/A
- AVG Volume (30 Days)
- BTM 176.4K
- ASBP 191.2K
- Earning Date
- BTM 05-13-2025
- ASBP 05-24-2025
- Dividend Yield
- BTM N/A
- ASBP N/A
- EPS Growth
- BTM N/A
- ASBP N/A
- EPS
- BTM N/A
- ASBP N/A
- Revenue
- BTM $573,703,000.00
- ASBP N/A
- Revenue This Year
- BTM $7.48
- ASBP N/A
- Revenue Next Year
- BTM $0.05
- ASBP N/A
- P/E Ratio
- BTM N/A
- ASBP N/A
- Revenue Growth
- BTM N/A
- ASBP N/A
- 52 Week Low
- BTM $0.93
- ASBP $0.40
- 52 Week High
- BTM $3.52
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- BTM 55.07
- ASBP N/A
- Support Level
- BTM $1.27
- ASBP N/A
- Resistance Level
- BTM $1.42
- ASBP N/A
- Average True Range (ATR)
- BTM 0.10
- ASBP 0.00
- MACD
- BTM 0.01
- ASBP 0.00
- Stochastic Oscillator
- BTM 89.47
- ASBP 0.00
About BTM Bitcoin Depot Inc.
Bitcoin Depot Inc owns and operates the largest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.